Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Froudarakis

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
Chest|September 16, 2000
Pleurodesis: everything flowsD Bouros, M Froudarakis, N M Siafakas
Chest|July 14, 2001
Cryotherapy in early superficial bronchogenic carcinomaN Deygas, M Froudarakis, G Ozenne, et al.
Annales De Medecine Interne|January 1, 1994
[Myopericarditis complicating Q fever]A Gikas, M Froudarakis, G Nicolaidis, et al.
The European Respiratory Journal|February 3, 2009
VATS or simple talc poudrage under medical thoracoscopy for recurrent spontaneous pneumothoraxJ-M Tschopp, J-M Schnyder, M Froudarakis, et al.
The European Respiratory Journal|November 1, 1995
BOOP presenting with haemoptysis and multiple cavitary nodulesM Froudarakis, D Bouros, R Loire, et al.
Respiration; International Review of Thoracic Diseases|December 22, 2000
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor supportE Briasoulis, M Froudarakis, H J Milionis, et al.
Oncology|March 1, 1996
Bronchial carcinoids. A review of 22 casesM Froudarakis, P Fournel, G Burgard, et al.
Medical Oncology (Northwood, London, England)|June 29, 2000
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancerM I Koukourakis, A Giatromanolaki, S Kakolyris, et al.
Revue Des Maladies Respiratoires|May 23, 2021
[Silica causes difficulties]S Pointel, P Gay, F Forest, et al.
European Review for Medical and Pharmacological Sciences|November 3, 2021
Feasibility and safety of treatment switch from Pirfenidone to Nintedanib in patients with idiopathic pulmonary fibrosis: a real-world observational studyP Ntolios, K Archontogeorgis, S Anevlavis, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
Chest|September 16, 2000
Pleurodesis: everything flowsD Bouros, M Froudarakis, N M Siafakas
Chest|July 14, 2001
Cryotherapy in early superficial bronchogenic carcinomaN Deygas, M Froudarakis, G Ozenne, et al.
Annales De Medecine Interne|January 1, 1994
[Myopericarditis complicating Q fever]A Gikas, M Froudarakis, G Nicolaidis, et al.
The European Respiratory Journal|February 3, 2009
VATS or simple talc poudrage under medical thoracoscopy for recurrent spontaneous pneumothoraxJ-M Tschopp, J-M Schnyder, M Froudarakis, et al.
The European Respiratory Journal|November 1, 1995
BOOP presenting with haemoptysis and multiple cavitary nodulesM Froudarakis, D Bouros, R Loire, et al.
Respiration; International Review of Thoracic Diseases|December 22, 2000
Chemotherapy-induced noncardiogenic pulmonary edema related to gemcitabine plus docetaxel combination with granulocyte colony-stimulating factor supportE Briasoulis, M Froudarakis, H J Milionis, et al.
Oncology|March 1, 1996
Bronchial carcinoids. A review of 22 casesM Froudarakis, P Fournel, G Burgard, et al.
Medical Oncology (Northwood, London, England)|June 29, 2000
Phase I/II dose escalation study of docetaxel and carboplatin combination supported with amifostine and GM-CSF in patients with incomplete response following docetaxel chemo-radiotherapy: additional chemotherapy enhances regression of residual cancerM I Koukourakis, A Giatromanolaki, S Kakolyris, et al.
Revue Des Maladies Respiratoires|May 23, 2021
[Silica causes difficulties]S Pointel, P Gay, F Forest, et al.
European Review for Medical and Pharmacological Sciences|November 3, 2021
Feasibility and safety of treatment switch from Pirfenidone to Nintedanib in patients with idiopathic pulmonary fibrosis: a real-world observational studyP Ntolios, K Archontogeorgis, S Anevlavis, et al.
Pageof 3